Antiviral activity of copper contact surfaces against MS2 coliphage and hepatitis a virus

Juan C Camacho1, Y Carol Shieh1, Benjamin W Redan1

  • 1Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, 6502 S. Archer Rd, Bedford Park, IL 60501, USA.

PubMed
Abstract

Insights

Copper surfaces effectively inactivate MS2 bacteriophage, especially in acidic conditions and simple media. However, MS2 may not accurately represent Hepatitis A virus (HAV) inactivation on copper.

Area of Science:

  • Food safety
  • Microbiology
  • Materials science

Background:

  • Viral cross-contamination from non-food contact surfaces to food products is a significant public health concern.
  • Understanding virus-metal interactions is crucial for developing effective strategies to mitigate transmission risks.

Purpose of the Study:

  • To investigate the inactivation of MS2 bacteriophage and Hepatitis A virus (HAV) on metal surfaces, specifically copper.
  • To evaluate factors influencing viral inactivation on copper, including environmental conditions and media composition.
  • To assess the suitability of MS2 as a surrogate for HAV in copper inactivation studies.

Main Methods:

  • MS2 bacteriophage and HAV were exposed to 99.9% copper surfaces.
  • Viral stability and inactivation rates were measured under various conditions (pH, media composition, food matrices).
  • FRhK-4 cell infectivity assays were used to determine HAV survival.

Main Results:

  • MS2 was stable on stainless steel but inactivated on copper (0.95 log10 PFU min-1).
  • Copper demonstrated greater MS2 inactivation in acidic (pH 3.5) and simple media (PBS) compared to protein-rich media.
  • HAV exhibited longer survival on copper than MS2 under tested conditions (0.17 log10 PFU min-1 reduction).

Conclusions:

  • Copper surfaces enhance viral inactivation, particularly in acidic environments and simple solutions.
  • The effectiveness of copper for viral inactivation is influenced by the surrounding medium.
  • MS2 may not be a reliable surrogate for HAV when evaluating viral inactivation on copper surfaces.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...